Of course, more in vitro and in vivo studies are needed to verify the relationship and mechanism between HMOX1, MMP9, and TNFRSF11B and anti-PD1/PD-L1 therapy in HCC. This evidence concerns the gene CD274 and hepatocellular carcinoma.